Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 124 for “"MarketScan"”.
-
Respiratory Infections and Risk for Development of Narcolepsy: Analysis of the Truven Health MarketScan Database (2008 to 2010) with Additional Assessment of Incidence and Prevalence
… reduced in exposure. Methods: The Truven Health MarketScan Commercial Dissertation Database (THMCDD) was used to estimate prevalence and incidence of narcolepsy, with and without cataplexy, by age groups, gender, and region among patients under age 66 with continuous enrollment for years …
-
A study assessing the characteristics of big data environments that predict high research impact: application of qualitative and quantitative methods
… (VHA), and private sources of data from IBM MarketScan and Optum, using social network analysis. We analyzed a battery of research impact measures as a function of the data sources. Other main predictors were topic clusters and authors’ social influence. Additionally, we conducted key …
-
Use of statistical analysis, data mining, decision analysis and cost effectiveness analysis to analyze medical data : application to comparative effectiveness of lumpectomy and mastectomy for breast cancer.
… Sample (NIS) 2005, the Thomson Reuter's MarketScan 2000 - 2001, the medical literature on clinical trials and online individuals' posts in discussion boards on breastcancer.org. The NIS was used to compare lumpectomy to mastectomy in terms of hospital length of stay, total charges and …
-
Investigating Infection-Related Hospitalization as a Risk Factor for Incident Heart Failure and Mortality among Heart Failure Patients
… leveraged the strengths of large claims data (MarketScan) and a community-based study (ARIC) to address these limitations and parse out the dynamic relationship between infection-related hospitalization and HF with several manuscripts. The first manuscript, a case-crossover study of …
-
Methods for drug safety signal detection using Real- World Data
… Practice Research Datalink (CPRD, UK), Merative MarketScan Commercial Claims and Medicare (US) and the ‘Système National des Données de Santé’ (SNDS, France). Results: The 101 articles included in the systematic review suggested that no method for drug safety signal detection in RWD can achieve …
-
Promoting Access to Hepatitis C Treatment: Policies and their Impacts on Patients and Society
… a regression discontinuity design with Truven MarketScan outpatient and pharmacy claims data. A single interrupted time series model was used to measure the changes in medication adherence from before to after DAA initiation, using Truven MarketScan pharmacy claims data. The budget impact of …
-
Optimization of Signal-Detection Methods in Novel Databases: a Focus on Direct-Acting Antivirals
… commercially insured patients form the Merative MarketScan Research Databases. Subgroup analysis can address confounding and further classify signals to be investigated. Logistic regression-based signal detection algorithms are superior to disproportionality analysis due to their ability to …
-
Data mining techniques for temporal point processes applied to insurance claims data
… of new methods for data extracted from the MarketScan® database. We summarize the results of applying popular kernels, as well as new kernels constructed specifically for this task, for support vector machines on data derived from this database. We were able to predict patients at risk of …
-
Statistical methods for assessing treatment effects for observational studies.
… (IV) are investigated through application to MarketScan insurance claims data. Each of these methods is used to compare BMP versus autograft spinal surgeries for the outcomes length of stay, complications, and cost. Recommendations are made as to when each particular method may or may not be …
-
Antibiotics and acute respiratory tract infections: a policy evaluation of the CDC’s Get Smart about Antibiotics campaign.
… which is nationally representative, and (2) the MarketScan claims database, which includes patients enrolled in large employer-sponsored health insurance plans. The odds that any antibiotics were prescribed were reduced after the publication of CPGs (MEPS: OR=0.68, p-value=0.01) and after the …
-
Perception, Payment, and Pollution- Examining the Effects of Air Quality on Health and Healthcare
… on average. The second chapter includes Merative MarketScan commercial insurance claims data to test whether these changes translate into a behavioral response. Results show that the same time periods were associated with higher spending, ranging from $0.65 to $2.00 per enrollee per day. Finally, …
-
Comparing Costs and Predictors of Low-Value Healthcare Service Use Among Primary Care Nurse Practitioners in the Southwest United States
… A secondary data analysis of the Merative™ MarketScan® 2021 databases was conducted. LVHS prevalence was lower or fairly equal to that of other studies, and direct claim costs were very-low cost. Extremely high low-value lumbar radiographic imaging claim costs were found in Nevada, New …
-
ASSESSING POTENTIALLY INAPPROPRIATE MEDICATION USE IN PATIENTS AT RISK FOR ADVERSE DRUG EFFECTS: SPIRONOLACTONE AS A CASE STUDY
… adults. We used commercial claims data from MarketScan and electronic health record data from the Geisinger Health System to identify predictors of spironolactone initiation among patients with heart failure, and used target trial emulation to characterize the risk of hyperkalemia and acute …
-
Evaluating Methods to Estimate United States Multiple Sclerosis Prevalence from Administrative Health Claims Data
… with MS were identified in AHC data from IBM® MarketScan® Research Databases – one of the largest samples of employer-sponsored health plan data comprised of over 250 million unique patients since 1995.6 Multiple Sclerosis patients were identified based on inpatient, outpatient, and …
-
Adherence to Oral Migraine Prophylaxis Medications in Patients with Chronic Migraine
… world data from large claims databases such as MarketScan. <br> <bold>OBJECTIVE</bold> The aim of this study is to describe the chronic migraine population through a large US insurance claims database from 2008 to 2011 and to assess adherence, switching, and resource use among patients taking …
-
UTILIZATION OF HORMONAL CONTRACEPTIVES AMONG CHILD-BEARING AGE WOMEN WITH SICKLE CELL DISEASE
… We conducted a cross-sectional study using IBM MarketScan® Research Databases from 2010 to 2019, focusing on childbearing-aged women with sickle cell disease and comparing them to women of the same age range using levothyroxine. We used the proportion of hormonal contraceptive users and the …
-
DEVELOPMENT AND VALIDATION OF A MODERN PRESCRIPTION-BASED RISK SCORE TO PREDICT HEALTHCARE SPENDING
… a retrospective cohort study using Merative MarketScan administrative claims data from continuously enrolled, commercially insured adults between January 2021 and December 2022 to develop and validate a modern, prescription-based risk score for predicting healthcare expenditures. Prescription …
-
Predicting Medical Diagnoses from Pharmaceutical Claims Data
… neural network classifier, training them on the MarketScan© commercial claims data and considering their feasibility. Both models pick up trends in the data based on peak f1-score and individual evaluation of output, but while the logistic model is able to recreate logical associations between …
-
Healthcare Resource Utilization and Costs in Patients with Mantle Cell Lymphoma in the Third-Line Setting in the US
… Methods: Retrospective cohort study using MarketScan health insurance claims data. The Merative™ MarketScan® Databases are U.S. claims datasets with de-identified medical and pharmacy claims linked to enrollment data for individuals with commercial or Medicare supplemental insurance. …
-
Biosimilars in the United States: Market Dynamics and Patient Out-of-Pocket Costs
… Set (5% sample) for Medicare and the MerativeTM MarketScan® Commercial Database for the commercial population were used as data sources, using price and volume (number of claims) for the following biologics: filgrastim, rituximab, infliximab, trastuzumab, pegfilgrastim, epoetin alfa, bevacizumab, …
Page 1 of 7